Core Insights - The edible oil industry in China is characterized by a complex supply chain that includes agricultural production, processing, packaging, and sales channels [1] - Major listed companies in the industry include Jinlongyu (300999.SZ), Shenliang Holdings (000019.SZ), and others, with Jinlongyu leading in revenue and market share [1][8] Industry Overview - The edible oil supply chain consists of upstream agricultural production, midstream processing companies, and downstream sales channels [1] - The industry has seen a decline in revenue across most listed companies in 2024, indicating increased competition and market pressure [8][15] Company Performance - Jinlongyu reported a revenue of 238.87 billion yuan in 2024, maintaining a leading position despite a decline of 10.37% in its feed raw materials and oil technology business [8][15] - Shenliang Holdings and Jinlongyu both experienced growth in net profit in Q1 2025, with increases of 42.97% and 11.24% respectively [9][10] - Other companies like Su Kuan Agricultural Development and Jingliang Holdings faced significant revenue declines in 2024 [10] Financial Metrics - As of May 27, 2025, Jinlongyu's total market capitalization reached 165.196 billion yuan, while other companies like Su Kuan Agricultural Development also exceeded 10 billion yuan [9][10] - The profit margins varied significantly among companies, with West King Food achieving a gross margin of 22.86%, while Jinlongyu and Shenliang Holdings reported margins below 3% [18] Business Strategies - Jinlongyu plans to expand into the health industry and enhance its product offerings through technological innovation [22][24] - Jingliang Holdings aims to strengthen its supply chain and marketing strategies to improve its trade business [22][24] - West King Food focuses on brand building and cost control to enhance competitiveness [22][24] Market Dynamics - The overseas revenue distribution among companies is uneven, with West King Food and others relying heavily on international markets, although some have seen declines in overseas sales [20][21] - The edible oil industry is facing challenges due to increased competition and market pressures, leading to varied performance among listed companies [15][18]

转自：前瞻产业研究院 行业主要上市公司：金龙鱼(300999.SZ)、深粮控股(000019.SZ)、金健米业(600127.SH)、京粮控股 (000505.SZ)、道道全(002852.SZ)、嘉华股份(603182.SH)、西王食品(000639.SZ)等 本文核心数据：食用油行业企业成本构成;价格传导机制;食用油行业价值链 1、食用油生产制备中，原材料是最大的成本构成 前瞻统计了中国食用油行业中，四家竞争力较强的上市公司食用油生产成本数据，可以看出，食用油的原材 料成本较高，2024年西王食品植物食用油原料成本占比74.39%，索宝蛋白、金健米业、嘉华股份的食用油 业务原材料成本占比都超过了92%;人工成本相对较低，在0.85%至1.51%不等，制造费用在0.6%至5.9%范围 内波动。 从中国食用油上市企业金健米业食用油产品的成本结构来看，2019-2024年，直接材料的占比在95%水平， 且呈波动上升趋势，表明受原材料价格波动影响较大;包装费用占比波动下滑，从2019年4.76%降至2024年的 3.1%;制造费用整体呈下降趋势，从2019年1.04%降至2024年的0.61%;直接人工费用在0. ...

Group 1 - The core stock price of Jiahua Co., Ltd. (603182) closed at 13.81 yuan on July 11, 2025, reflecting a 2.37% increase from the previous week's closing price of 13.49 yuan [1] - The stock reached a nearly one-year high of 13.95 yuan during intraday trading on July 11, with a low of 13.39 yuan on July 7 [1] - The current total market capitalization of Jiahua Co., Ltd. is 2.272 billion yuan, ranking 21st out of 22 in the agricultural product processing sector and 4851st out of 5149 in the A-share market [1] Group 2 - Jiahua Co., Ltd. plans to use up to 50 million yuan of its own funds for hedging activities related to raw material soybeans [1] - The company will employ various financial instruments, including but not limited to futures, options, forwards, swaps, and combinations thereof, for this hedging strategy [1] - The board of directors has approved this plan, which does not require shareholder meeting approval, and the trading period is set for 12 months from the date of board approval [1]

Core Viewpoint - The company aims to utilize futures and derivatives trading to hedge against significant fluctuations in raw material prices, specifically soybeans, to ensure stable operations and development [1][2][3]. Group 1: Trading Purpose and Instruments - The primary purpose of the trading is to leverage the hedging functions of the futures market to mitigate adverse impacts from raw material price volatility on the company's operations [1][2]. - The trading instruments include futures, options, forwards, swaps, and combinations of these financial tools [1][4]. - The company plans to use its idle self-owned funds for the hedging activities, with a maximum investment of RMB 50 million [2][3]. Group 2: Trading Amount and Sources - The expected maximum balance for margin and premiums related to futures and derivatives trading is set at RMB 50 million, which can be used cyclically within the approval period [2][3]. - The funding for these trading activities will come from the company's own funds, without involving raised capital [3][4]. Group 3: Trading Procedures and Risk Management - The board of directors approved the adjustment of the hedging business on July 10, 2025, which does not require shareholder approval [2][4]. - The company will engage in trading at recognized domestic and foreign exchanges, including the Shanghai Futures Exchange and Dalian Commodity Exchange [3][4]. - A comprehensive risk management system is in place to address potential market, liquidity, operational, and credit risks associated with the trading activities [5][6]. Group 4: Impact on Company Operations - The trading activities are expected to enhance the company's ability to manage raw material price risks effectively, thereby supporting stable operational performance [5][6]. - The accounting treatment for the futures and derivatives trading will comply with relevant financial reporting standards [6].

重要内容提示： 交易目的：为充分利用期货市场的套期保值功能，规避和减少因原材料 价格大幅波动对公司生产经营造成的不利影响，促进公司稳健发展，公司拟使用 部分闲置自有资金开展与生产经营有直接关系的原材料的套期保值业务。 交易品种：主要是与公司生产经营相关的原材料大豆。 证券代码：603182 证券简称：嘉华股份 公告编号：2025-017 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 交易工具：包括但不限于期货、场内期权、远期、收益互换、场外期权、 外汇远期、掉期、货币互换、利率互换等金融工具及上述金融工具的组合。 交易场所：经依法批准或者核准，具有期货和衍生品交易业务经营资格 的场内交易场所或场外交易机构。 山东嘉华生物科技股份有限公司 关于调整套期保值业务相关事项的公告 交易金额：公司开展期货和衍生品交易业务预计投入的保证金和权利金 最高余额不超过人民币 5,000.00 万元，该额度在审批期限内可循环滚动使用。 履行的审议程序：公司于 2025 年 7 月 10 日召开第六届董事会第四次会 议，审议通过了《关于调整套期保 ...

Core Insights - The article provides a comprehensive overview of the edible oil industry chain in China, detailing its various segments including oilseed cultivation, pressing, refining, packaging, and sales channels [1][5]. Industry Overview - The edible oil industry in China comprises numerous companies, with key producers including Jinlongyu, Shandong Luhua, Shanghai Liangyou, Jingliang Holdings, Jinjian Rice Industry, Xiwang Food, Daodaoquan, and COFCO Technology [2][5]. - The upstream raw materials are sourced from various agricultural enterprises, while downstream consumers include restaurants and e-commerce platforms like JD.com and Alibaba [2]. Regional Distribution - As of May 30, 2025, there are 60,329 registered companies in the edible oil industry chain in China, with Shandong province having the highest number at 5,946, followed by Hunan (5,269), Henan (4,519), and Sichuan (3,762), collectively accounting for 32.3% of the total [5][6]. - The geographical distribution of edible oil companies is closely linked to transportation convenience and agricultural production capabilities [5]. Listed Companies - Among the listed companies in the edible oil sector, 10 have disclosed revenue data related to edible oil, with a concentration in coastal regions. Notable companies include Xiwang Food and Jiahua in Shandong, Daodaoquan and Jinjian Rice Industry in Hunan, and Jinlongyu in Shanghai [6][10]. Industrial Parks - There are nearly 40 industrial parks related to edible oil production in China, primarily located in Sichuan (6 parks), followed by Henan and Zhejiang (4 parks each). Despite Shandong having the most companies, it has only 3 industrial parks, indicating a dispersed nature of edible oil enterprises in the province [10].

Group 1 - The core point of the article is that Jia Hua Co., Ltd. (603182) announced its annual equity distribution for 2024, with a cash dividend of 0.1 yuan per share, totaling 16,455,000 yuan [2][4] - On May 23, 2025, Jia Hua's stock closed at 13.15 yuan, down 1.87%, with a turnover rate of 4.36% and a trading volume of 40,600 shares, amounting to a transaction value of 53.7152 million yuan [1] - The fund flow on May 23 showed a net outflow of 515.35 thousand yuan from main funds, while speculative funds had a net inflow of 362.46 thousand yuan, and retail investors saw a net inflow of 152.89 thousand yuan [2][4] Group 2 - The equity distribution announcement includes details such as the ex-dividend date on May 30, 2025, and the record date on May 29, 2025 [2][4] - The cash dividend distribution will be handled by China Securities Depository and Clearing Corporation Limited, Shanghai Branch, with varying tax burdens for different types of shareholders [2]

每股分配比例 A 股每股现金红利0.1元 山东嘉华生物科技股份有限公司2024年年度权益分派 实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603182 证券简称：嘉华股份 公告编号：2025-016 重要内容提示： 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/5/29 | － | 2025/5/30 | 2025/5/30 | 差异化分红送转： 否 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 15 日的2024年年度股东大会审议通过。 二、 分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本164,550,000股为基数 ...

证券代码：603182 证券简称：嘉华股份 公告编号：2025-015 山东嘉华生物科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 5 月 15 日 (二)股东大会召开的地点：公司会议室（山东省聊城市莘县鸿图街 19 号） (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 111 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 66,066,968 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 40.1500 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议由董事长李广庆先生主持，采用现场投票和网络投票相结合的方式 表决，会议的召集、召开程序及出席会议人员的资格均符合《公司法》和《公司 ...

北京市京师（青岛）律师事务所 关于山东嘉华生物科技股份有限公司 2024年年度股东大会的 法律意见书 地址：山东省青岛市崂山区海尔路83号金鼎大厦14层 电话：0532-85953988 传真：0532-85953977 网址：http://www.jingsh.com 二〇二五年五月 北京市京师（青岛）律师事务所 关于山东嘉华生物科技股份有限公司 2024年年度股东大会的 法律意见书 致：山东嘉华生物科技股份有限公司 北京市京师（青岛）律师事务所（以下简称"本所"）接受山东嘉华生物科 技股份有限公司（以下简称"公司"）委托，就公司2024年年度股东大会（以下 简称"本次股东大会"）的相关事宜出具《北京市京师（青岛）律师事务所关于 山东嘉华生物科技股份有限公司2024年年度股东大会的法律意见书》（以下简称 "本《法律意见书》"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）《中 华人民共和国证券法》（以下简称"《证券法》"）《上市公司股东会规则 （2025修订）》（以下简称"《股东会规则》"）《上海证券交易所上市公司自 律监管指引第1号—规范运作（2023年12月修订）》和《山东嘉华生物科 ...